Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+44.7%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
3x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $67.81M | +33.9% |
| 2024 | $50.64M | -23.4% |
| 2023 | $66.08M | +195.1% |
| 2022 | $22.39M | -21.8% |
| 2021 | $28.65M | - |